Background: The combination of fludarabine, clofarabine and busulfan has a cytotoxic effect on AML cells; the authors investigated the effect of adding the HDAC inhibitor suberoylanilide hydroxamic acid (SAHA) to the triple combination. The gene discussed is HDAC9; the disease is acute myeloid leukemia.